WUPI - Internal Medicine - Medical Oncology

Fingerprint Dive into the research topics where WUPI - Internal Medicine - Medical Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

    Schroeder, M. A., Jean Khoury, H., Jagasia, M., Ali, H., Schiller, G. J., Staser, K., Choi, J., Gehrs, L., Arbushites, M. C., Yan, Y., Langmuir, P., Srinivas, N., Pratta, M., Perales, M. A., Chen, Y. B., Meyers, G. & DiPersio, J. F., Apr 28 2020, In : Blood Advances. 4, 8, p. 1657-1669 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma

    Goldsmith, S. R., Fiala, M. A., Wang, B., Schroeder, M. A., Wildes, T. M., Ghobadi, A., Stockerl-Goldstein, K. & Vij, R., May 1 2020, In : Annals of Hematology. 99, 5, p. 1041-1048 8 p.

    Research output: Contribution to journalArticle